tetano
Editor, Senior Moderator
Biosaf Health
. 2021 Dec 28.
doi: 10.1016/j.bsheal.2021.12.005. Online ahead of print.
Laboratory biosafety measures of SARS-CoV-2 at containment level 2 with particular reference to its more infective variants
Wafa Naeem[SUP] 1 [/SUP], Habiba Zeb[SUP] 1 [/SUP], Muhammad Ibrahim Rashid[SUP] 1 [/SUP]
Affiliations
Abstract
The novel betacoronavirus (Severe Acute Respiratory Syndrome Coronavirus 2, SARS-CoV-2) is a pathogen that causes deadly respiratory disease coronavirus disease 2019 (COVID-19). The incidence of this disease has increased in the last few months affecting 257,832,881 people in 221 countries and 51,68,069 deaths worldwide according to Worldometer at 04:03 GMT on November 22, 2021.Thus, the emergence of this disease creates a challenge for health care providers in handling this pathogen and reducing its risk of transmission. In developing countries, this virus is treated in biosafety level 2 laboratories, where a high concentration of pathogen can easily affect the laboratory staff and cause the spread of this disease. Based on the epidemiology and characteristics of the SARS-CoV-2 virus already discussed in recent studies, we will provide biosafety guidelines and suggestions for safe handling and transportation of the SARS-CoV-2 virus in dealing with the current pandemic situation with a focus on increased infectivity of emerging new variants.
Keywords: Biosafety guidelines; COVID-19; Laboratory acquired infections; PPE; SARS-CoV-2.
. 2021 Dec 28.
doi: 10.1016/j.bsheal.2021.12.005. Online ahead of print.
Laboratory biosafety measures of SARS-CoV-2 at containment level 2 with particular reference to its more infective variants
Wafa Naeem[SUP] 1 [/SUP], Habiba Zeb[SUP] 1 [/SUP], Muhammad Ibrahim Rashid[SUP] 1 [/SUP]
Affiliations
- PMID: 34977531
- PMCID: PMC8713415
- DOI: 10.1016/j.bsheal.2021.12.005
Abstract
The novel betacoronavirus (Severe Acute Respiratory Syndrome Coronavirus 2, SARS-CoV-2) is a pathogen that causes deadly respiratory disease coronavirus disease 2019 (COVID-19). The incidence of this disease has increased in the last few months affecting 257,832,881 people in 221 countries and 51,68,069 deaths worldwide according to Worldometer at 04:03 GMT on November 22, 2021.Thus, the emergence of this disease creates a challenge for health care providers in handling this pathogen and reducing its risk of transmission. In developing countries, this virus is treated in biosafety level 2 laboratories, where a high concentration of pathogen can easily affect the laboratory staff and cause the spread of this disease. Based on the epidemiology and characteristics of the SARS-CoV-2 virus already discussed in recent studies, we will provide biosafety guidelines and suggestions for safe handling and transportation of the SARS-CoV-2 virus in dealing with the current pandemic situation with a focus on increased infectivity of emerging new variants.
Keywords: Biosafety guidelines; COVID-19; Laboratory acquired infections; PPE; SARS-CoV-2.